Package 51662-1431-1

Brand: glycopyrrolate

Generic: glycopyrrolate
NDC Package

Package Facts

Identity

Package NDC 51662-1431-1
Digits Only 5166214311
Product NDC 51662-1431
Product ID 51662-1431_2b382c02-1322-a447-e063-6394a90ac5c1
Description

5 mL in 1 VIAL (51662-1431-1)

Marketing

Marketing Status
Marketed Since 2019-12-21
Brand glycopyrrolate
Generic glycopyrrolate
Sample Package No

Linked Drug Pages (1)

GLYCOPYRROLATE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "2b382c02-1322-a447-e063-6394a90ac5c1", "openfda": {"upc": ["0370121139614", "0370121139416"], "unii": ["V92SO9WP2I"], "rxcui": ["238212", "1731582"], "spl_set_id": ["9a3a142c-daaf-79af-e053-2995a90a1c51"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "5 mL in 1 VIAL (51662-1431-1)", "package_ndc": "51662-1431-1", "marketing_start_date": "20191221"}], "brand_name": "GLYCOPYRROLATE", "product_id": "51662-1431_2b382c02-1322-a447-e063-6394a90ac5c1", "dosage_form": "INJECTION", "pharm_class": ["Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "51662-1431", "generic_name": "GLYCOPYRROLATE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GLYCOPYRROLATE", "active_ingredients": [{"name": "GLYCOPYRROLATE", "strength": "1 mg/5mL"}], "application_number": "ANDA208973", "marketing_category": "ANDA", "marketing_start_date": "20191221", "listing_expiration_date": "20261231"}